Explore how probiotics May Support Immune Health
Every Year, Cold and Flu Season Effects Millions of Children World Wide
In Canada alone, influenza leads to over 12,000 hospitalizations and 3,500 deaths each year. Many children also experience gastrointestinal infections, such as rotavirus and norovirus, which can result in doctor visits, emergency room trips, or hospitalization. Recovering from these illnesses can take time and place additional stress on families, including missed school, care leave, and general discomfort.
While vaccines arean important tool, fewer than 1 in 3 school-aged children receive the flu vaccine. For the common cold, treatment options are limited, as many over-the-counter medications are not recommended or lack strong evidence of effectiveness. This leaves parents and healthcare providers seeking safe, evidence-based alternatives.
KGK Science is conducting a clinical study to investigate a natural probiotic strain, Bacillus coagulans SNZ 1969®, which help reduce the frequency, duration and severity of:
Upper Respiratory Tract Infections (URTI) example, Common cold with symptoms such as runny nose, congestion, sore throat, and cough
Gastrointestinal Tract Infections (GITIs)- with symptoms such as Upset stomach, diarrhea and related symptoms
What Participation Involves
- Children 6–12 years old who are currently attending school may be eligible
- Participation will take place through the 2025–2026 cold and flu season
- Parents will complete simple symptom questionnaires to track their child’s health
- All study-related products and assessments are provided at no cost
- Blood samples are collected using child-friendly techniques, including small needles and numbing cream, to help make the process as comfortable as possible for your child.
- Quick and simple at-home saliva collection for immune health testing.
- At-home stool sample collection with clear, simple instructions to help researchers study gut health
- Participants may contribute valuable insights that could help shape future options for supporting children’s immune health
This study has been reviewed by Health Canada and an independent Research Ethics Board with your child’s safety as top priority.
To be Eligible for This study You Must be:
- Children 6-12
- Are in general good health
- No Immunosuppressant
- No severe environmental allergies
- Available for 3 in-clinic & 2 virtual visits over 3 months
Participants will be compensated $1000 for their time
If interested in participating in this study, sign up below by completing our Eligibility questionnaire
Have any questions about this study?
Please email us
or call us at
